课题基金 / 基金详情

Targeting the eicosanoid/macrophage axis to enhance host defense against influenza virus infection

Targeting the eicosanoid/macrophage axis to enhance host defense against influenza virus infection
靶向类二十烷酸/巨噬细胞轴增强宿主对流感病毒感染的防御
批准号：
408304
负责人：
Divangahi Maziar
金额：
$53.22万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-09-01 至 2024-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=408304&lang=en
关键词：
Host Lipid Mediators Immune Response Influenza Virus Infection Macrophages Respiratory Infection

项目摘要

项目成果

Divangahi Maziar的其他基金

相似基金

相关文献

中文摘要
翻译
尽管在世界范围内应用了疫苗接种和其他抗病毒干预措施，但流感感染仍然是对人类健康的持续威胁。1918年的“西班牙”流感大流行仅在一年内就造成大约4000万人死亡。类似t
英文摘要
Despite the world-wide application of vaccination and other anti-viral interventions, influenza infection remains a persistent threat to human health. The 1918 "Spanish" influenza pandemic killed approximately 40 million people in just one year. Similar t
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing a novel vaccine against COVID-19
Reprogramming HSCs to generate protective trained immunity against TB
Monocyte/Macrophage Biology Symposium: Cracking the Macrophage Code in Host Defense and Tolerance
Regulation of Anti-Microbial Macrophage Response to Pulmonary Infections
海外基金